{
  "PHUN": {
    "ticker": "PHUN",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-05T13:32:22Z",
        "headline": "Phunware Names Rahul Mewawalla As Chairman Of The Board To Lead Growth And Innovation In AI, Predictive Analytics, And Cloud Services",
        "id": 41744244,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "PHUN"
        ],
        "updated_at": "2024-11-05T13:32:23Z",
        "url": "https://www.benzinga.com/news/24/11/41744244/phunware-names-rahul-mewawalla-as-chairman-of-the-board-to-lead-growth-and-innovation-in-ai-predicti"
      },
      {
        "author": "Pooja Rajkumari",
        "content": "",
        "created_at": "2024-11-06T09:38:06Z",
        "headline": "Trump's Potential Return To White House Sends Ex-President Linked Phunware Stock Upwards During Pre-Market Hours",
        "id": 41767332,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2024/11/06/Washington--Dc---April-27--2018-Us-Presi.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2024/11/06/Washington--Dc---April-27--2018-Us-Presi.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2024/11/06/Washington--Dc---April-27--2018-Us-Presi.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": " Investors seem optimistic about the company&#39;s future prospects should Trump regain the presidency.",
        "symbols": [
          "PHUN"
        ],
        "updated_at": "2024-11-06T09:38:06Z",
        "url": "https://www.benzinga.com/markets/equities/24/11/41767332/trumps-potential-return-to-white-house-sends-ex-president-linked-phunware-stock-upwards-during-p"
      }
    ],
    "hod": false,
    "float": "11.23M",
    "price": "7.94",
    "time": "10:01:34",
    "isActive": false,
    "firstSeen": "2024-11-06T09:01:33.105Z",
    "lastSeen": "2024-11-06T10:11:16.365Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 1270000,
      "Avg. Daily Volume": 1150000,
      "Short Float": "11.31%",
      "Short Ratio": "1.11"
    }
  },
  "DATS": {
    "ticker": "DATS",
    "news": [],
    "hod": false,
    "float": "2.73M",
    "price": "2.78",
    "time": "10:03:27",
    "isActive": true,
    "firstSeen": "2024-11-06T09:03:54.187Z",
    "lastSeen": "2024-11-06T15:21:15.533Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 13690,
      "Avg. Daily Volume": 122770,
      "Short Float": "0.50%",
      "Short Ratio": "0.11"
    }
  },
  "CREV": {
    "ticker": "CREV",
    "news": [],
    "hod": false,
    "float": "1.75M",
    "price": "4.96",
    "time": "10:08:48",
    "isActive": false,
    "firstSeen": "2024-11-06T09:09:03.992Z",
    "lastSeen": "2024-11-06T09:21:47.161Z",
    "shorts": {}
  },
  "AREB": {
    "ticker": "AREB",
    "news": [],
    "hod": false,
    "float": "1.07M",
    "price": "3.34",
    "time": "10:22:35",
    "isActive": true,
    "firstSeen": "2024-11-06T09:22:56.439Z",
    "lastSeen": "2024-11-06T15:05:28.270Z",
    "shorts": {}
  },
  "PSTV": {
    "ticker": "PSTV",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T12:38:00Z",
        "headline": "Plus Therapeutics And SpectronRx Announced The Signing Of A Manufacturing Services Agreement For The Production Of Rhenium (186Re) Obisbemeda, An Innovative Radiotherapy For CNS Cancers, Including Leptomeningeal Metastases And Recurrent Glioblastoma",
        "id": 41771446,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "PSTV"
        ],
        "updated_at": "2024-11-06T12:38:00Z",
        "url": "https://www.benzinga.com/news/24/11/41771446/plus-therapeutics-and-spectronrx-announced-the-signing-of-a-manufacturing-services-agreement-for-the"
      }
    ],
    "hod": false,
    "float": "5.75M",
    "price": "1.97",
    "time": "13:32:09",
    "isActive": true,
    "firstSeen": "2024-11-06T12:32:25.686Z",
    "lastSeen": "2024-11-06T12:32:25.687Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 53960,
      "Avg. Daily Volume": 69080,
      "Short Float": "0.94%",
      "Short Ratio": "0.78"
    }
  },
  "ELWS": {
    "ticker": "ELWS",
    "news": [],
    "hod": true,
    "float": "5.36M",
    "price": "5.34",
    "time": "13:38:59",
    "isActive": true,
    "firstSeen": "2024-11-06T12:39:32.243Z",
    "lastSeen": "2024-11-06T15:18:32.340Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 16200,
      "Avg. Daily Volume": 708060,
      "Short Float": "N/A",
      "Short Ratio": "0.02"
    }
  },
  "PSQH": {
    "ticker": "PSQH",
    "news": [],
    "hod": false,
    "float": "17.63M",
    "price": "3.45",
    "time": "13:59:41",
    "isActive": true,
    "firstSeen": "2024-11-06T12:59:45.430Z",
    "lastSeen": "2024-11-06T12:59:45.430Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 1270000,
      "Avg. Daily Volume": 87190,
      "Short Float": "7.75%",
      "Short Ratio": "14.59"
    }
  },
  "APPS": {
    "ticker": "APPS",
    "news": [],
    "hod": false,
    "float": "91.10M",
    "price": "3.56",
    "time": "14:03:28",
    "isActive": true,
    "firstSeen": "2024-11-06T13:03:58.349Z",
    "lastSeen": "2024-11-06T13:03:58.349Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 5190000,
      "Avg. Daily Volume": 4139999.9999999995,
      "Short Float": "5.69%",
      "Short Ratio": "1.25"
    }
  },
  "TZUP": {
    "ticker": "TZUP",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T12:49:27Z",
        "headline": "Thumzup Media Stated That It Is Nearing Completion Of Developing Video Capabilities To Facilitate Its Proprietary AD Tech Platform's Integration With Instagram Reels",
        "id": 41771708,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "TZUP"
        ],
        "updated_at": "2024-11-06T12:49:27Z",
        "url": "https://www.benzinga.com/news/24/11/41771708/thumzup-media-stated-that-it-is-nearing-completion-of-developing-video-capabilities-to-facilitate-it"
      }
    ],
    "hod": false,
    "float": "2.48M",
    "price": "6.38",
    "time": "14:12:24",
    "isActive": true,
    "firstSeen": "2024-11-06T13:13:14.221Z",
    "lastSeen": "2024-11-06T13:13:14.221Z",
    "shorts": {}
  },
  "NUKK": {
    "ticker": "NUKK",
    "news": [],
    "hod": false,
    "float": "1.08M",
    "price": "2.98",
    "time": "14:18:52",
    "isActive": true,
    "firstSeen": "2024-11-06T13:19:25.897Z",
    "lastSeen": "2024-11-06T13:24:13.806Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 103420,
      "Avg. Daily Volume": 365210,
      "Short Float": "9.61%",
      "Short Ratio": "0.28"
    }
  },
  "REBN": {
    "ticker": "REBN",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T13:36:24Z",
        "headline": "Reborn Coffee Announced It Has Closed Its Acquisition Of A 58% Stake In South Korean Bbang Ssaem Bakery; Terms Not Disclosed",
        "id": 41773473,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "REBN"
        ],
        "updated_at": "2024-11-06T13:36:25Z",
        "url": "https://www.benzinga.com/news/24/11/41773473/reborn-coffee-announced-it-has-closed-its-acquisition-of-a-58-stake-in-south-korean-bbang-ssaem-bake"
      }
    ],
    "hod": false,
    "float": "2.49M",
    "price": "1.9",
    "time": "14:31:17",
    "isActive": true,
    "firstSeen": "2024-11-06T13:31:40.496Z",
    "lastSeen": "2024-11-06T13:45:38.361Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 36380,
      "Avg. Daily Volume": 139860,
      "Short Float": "1.29%",
      "Short Ratio": "0.26"
    }
  },
  "ICU": {
    "ticker": "ICU",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T14:09:50Z",
        "headline": "SeaStar Medical Announces The Receipt Of A Breakthrough Device Designation From The U.S. FDA CBER For The Co's Patented, Cell-Directed Selective Cytopheretic Device To Treat Chronic Systemic Inflammation In End-stage Renal Disease Patients Who Require Chronic Hemodialysis",
        "id": 41774599,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "ICU"
        ],
        "updated_at": "2024-11-06T14:11:14Z",
        "url": "https://www.benzinga.com/general/biotech/24/11/41774599/seastar-medical-announces-the-receipt-of-a-breakthrough-device-designation-from-the-u-s-fda-cber-"
      }
    ],
    "hod": false,
    "float": "3.99M",
    "price": "2.89",
    "time": "15:00:36",
    "isActive": true,
    "firstSeen": "2024-11-06T14:00:43.164Z",
    "lastSeen": "2024-11-06T14:29:26.204Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 208830,
      "Avg. Daily Volume": 100830,
      "Short Float": "5.45%",
      "Short Ratio": "2.07"
    }
  },
  "GLUE": {
    "ticker": "GLUE",
    "news": [],
    "hod": false,
    "float": "46.13M",
    "price": "9.67",
    "time": "15:29:16",
    "isActive": true,
    "firstSeen": "2024-11-06T14:29:26.199Z",
    "lastSeen": "2024-11-06T14:29:26.199Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 5230000,
      "Avg. Daily Volume": 356490,
      "Short Float": "11.73%",
      "Short Ratio": "14.68"
    }
  },
  "MGNX": {
    "ticker": "MGNX",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T12:25:03Z",
        "headline": "HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $4 Price Target",
        "id": 41770710,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "MGNX"
        ],
        "updated_at": "2024-11-06T12:25:04Z",
        "url": "https://www.benzinga.com/news/24/11/41770710/hc-wainwright-co-reiterates-neutral-on-macrogenics-maintains-4-price-target"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-05T21:14:22Z",
        "headline": "Macrogenics Q3 EPS $0.90 Beats $0.21 Estimate, Sales $110.71M Beat $76.11M Estimate",
        "id": 41758116,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "MGNX"
        ],
        "updated_at": "2024-11-05T21:14:22Z",
        "url": "https://www.benzinga.com/news/earnings/24/11/41758116/macrogenics-q3-eps-0-90-beats-0-21-estimate-sales-110-71m-beat-76-11m-estimate"
      }
    ],
    "hod": false,
    "float": "58.01M",
    "price": "4.72",
    "time": "15:29:01",
    "isActive": true,
    "firstSeen": "2024-11-06T14:29:26.204Z",
    "lastSeen": "2024-11-06T15:00:54.671Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 5370000,
      "Avg. Daily Volume": 808220,
      "Short Float": "9.25%",
      "Short Ratio": "6.64"
    }
  },
  "SONN": {
    "ticker": "SONN",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T14:42:38Z",
        "headline": "Sonnet BioTherapeutics Shares Resume Trade",
        "id": 41775820,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T14:42:38Z",
        "url": "https://www.benzinga.com/trading-ideas/24/11/41775820/sonnet-biotherapeutics-shares-resume-trade"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T14:34:49Z",
        "headline": "Sonnet BioTherapeutics Shares Halted On Circuit breaker To The Downside, Stock Now Up 106.9%",
        "id": 41775624,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T14:34:50Z",
        "url": "https://www.benzinga.com/trading-ideas/24/11/41775624/sonnet-biotherapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-106-9"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T13:33:55Z",
        "headline": "Sonnet BioTherapeutics Announces Issuance Of U.S. Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates; Both Novel Bifunctional And Monofunctional Fusion Proteins Exhibit Wild-Type Binding To The IL-18 Receptor, Coupled With Undetectable Binding To The Inhibitory IL-18 Binding Protein",
        "id": 41773340,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T13:33:55Z",
        "url": "https://www.benzinga.com/general/biotech/24/11/41773340/sonnet-biotherapeutics-announces-issuance-of-u-s-patent-covering-a-variant-il-18-incorporated-int"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T14:47:07Z",
        "headline": "Sonnet BioTherapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 85.3%",
        "id": 41775938,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T14:47:08Z",
        "url": "https://www.benzinga.com/trading-ideas/24/11/41775938/sonnet-biotherapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-85-3"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T14:56:42Z",
        "headline": "Sonnet BioTherapeutics Shares Resume Trading",
        "id": 41776141,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T14:56:43Z",
        "url": "https://www.benzinga.com/trading-ideas/24/11/41776141/sonnet-biotherapeutics-shares-resume-trading"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T18:21:04Z",
        "headline": "Sonnet BioTherapeutics Prices $5M Public Offering At-The-Market Under Nasdaq Rules, Selling 1.11M Shares And Warrants For Additional 2.22M Shares At $4.50 Per Share",
        "id": 41783044,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T18:21:05Z",
        "url": "https://www.benzinga.com/news/24/11/41783044/sonnet-biotherapeutics-prices-5m-public-offering-at-the-market-under-nasdaq-rules-selling-1-11m-shar"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2024-11-06T14:39:00Z",
        "headline": "Sonnet BioTherapeutics shares are trading higher after the company announced the issuance of a U.S. patent covering an IL-18 variant into two novel immunotherapeutic drug candidates.",
        "id": 41775666,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SONN"
        ],
        "updated_at": "2024-11-06T20:06:05Z",
        "url": "https://www.benzinga.com/wiim/24/11/41775666/sonnet-biotherapeutics-shares-are-trading-higher-after-the-company-announced-the-issuance-of-a-u-s-p"
      }
    ],
    "hod": false,
    "float": "645.32K",
    "price": "9",
    "time": "15:42:50",
    "isActive": true,
    "firstSeen": "2024-11-06T14:42:59.341Z",
    "lastSeen": "2024-11-06T15:28:20.015Z",
    "shorts": {
      "Settlement Date": "Oct 15, 2024",
      "Short Interest": 20840,
      "Avg. Daily Volume": 23930,
      "Short Float": "3.42%",
      "Short Ratio": "0.87"
    }
  }
}